Summit Therapeutics Inc. SEC filings SMMT

Summit Therapeutics Inc. has 564 filings in SEC EDGAR's recent list, going back to Mar 4, 2014. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on December 31.

Summit Therapeutics Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Apr 17, 2026 Dec 31, 2025
10-K Annual report Feb 23, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
10-K Annual report Feb 24, 2025 Dec 31, 2024
10-K Annual report Feb 20, 2024 Dec 31, 2023
10-K Annual report Mar 9, 2023 Dec 31, 2022
10-K/A Amended annual report Dec 21, 2022 Dec 31, 2021
10-K Annual report Mar 17, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Apr 30, 2020 Dec 31, 2019
20-F Annual report (foreign issuer) Mar 29, 2019 Jan 31, 2019
20-F Annual report (foreign issuer) Apr 13, 2018 Jan 31, 2018
20-F Annual report (foreign issuer) Mar 30, 2017 Jan 31, 2017
20-F Annual report (foreign issuer) May 12, 2016 Jan 31, 2016
20-F Annual report (foreign issuer) May 7, 2015 Jan 31, 2015

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SMMT (Nasdaq)
Fiscal year ends
December 31
Headquarters
Miami, FL
SEC filer status
Large accelerated filer
SEC CIK
1599298
Former names
Summit Therapeutics plc (until Sep 17, 2020); Summit Corp plc (until Jan 30, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.